Glypera™ effectively shields airway epithelia from sars-cov-2 infection and inflammatory events

HIGHLIGHTS

  • who: Viktoria Zaderer from the Written informed consent was obtained from all donors of leftover nasopharyngeal/ oropharyngeal specimen and EDTA blood by the participating clinicsThe Ethics Committee of the Medical University of Innsbruck (a copy is attached to the proposal, ECS1166/2020) approved the use of anonymized leftover specimens of , patients for scientific purposes. have published the Article: GlyPerAu2122 effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events, in the Journal: (JOURNAL)

SUMMARY

    Mutations within the receptor-binding domain (RBD), such continuously emerging VOCs are potentially less susceptible against currently . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?